SOURCE: ML Capital Group Inc.
FOUNTAIN HILLS, AZ--(Marketwired - May 12, 2014) - ML Capital Group, Inc. (OTCQB: MLCG) is pleased to announce that it has received its full product shipment of its branded SuperStar Vapor Pen.
The Company confirms that it has received its full initial order of its SuperStar Vapor Pen product line at its office facility in Arizona, and has commenced the distribution and sales of the product based upon its previous orders and a growing interest from its sales agents and distribution partners.
The SuperStar Vapor Pen product line is a premium 8-piece vapor pen kit, packaged in a professional black display case, with the pen being available in five distinct colors of black, gold, white, pink and red. The unique design and features of the SuperStar Vapor Pen set is that it can be used with both tobacco based products, as well as medical marijuana or cannabis in the form of liquid, wax, or dry weed. The Company also affirms that it has commenced placing SuperStar Vapor Pens with dispensaries, with the first initial placement being made in the Scottsdale-Fountain Hills area, with additional placement expected to take place throughout Arizona, California and Colorado in the near future.
ML Capital Group's President and CEO, Mrs. Lisa Nelson, commented, "We finally received our SuperStar Vapor Pen order and could not be happier! The initial reception for the product has been very strong with everybody that we've met with so far, in addition to several of our sales agents and distributors indicating a high degree of interest from specialty retail stores and dispensaries. Now that we can ship product -- we can ramp sales quickly and focus on our continued expansion and adopting new products under the SuperStar brand name."
Current photos of the recent shipment and of the SuperStar Vapor Pen on display can be found at the Company's website at: www.superstarvaporpens.com and are now available for purchase.
In other news -- based upon medical marijuana's growth and prominence in the marketplace -- we provide some interesting medical marijuana industry statistics that were found in a recent Huffington Post report. The estimated amount the U.S. legal marijuana market will be worth in five years is $10.2 billion; The amount of marijuana tax revenue Colorado is devoting to public school construction is $40 million; The estimated annual sales tax revenue generated by medical marijuana dispensaries in California is $105 million; and the estimated size of the medical marijuana market in Arizona in 2014 is $142.19 million, up from $35.37 million last year. Arizona has a record 80 medical marijuana dispensaries currently open, with more expected to open this year.
About ML Capital Group, Inc.:
ML Capital Group, Inc's primary business consists of providing management, financial and strategic consulting services designed to advance and improve an organization's ability to conduct its business more effectively and to foster sales growth, with a principal focus on assisting companies in the green technology industry as well as produces, markets and sells its own branded products that are specifically focused on the medical marijuana, or "green medicine," industry.
ML Capital Group's stock is traded on the OTC Bulletin Board and OTC Markets where it is qualified to be listed in the QB marketplace as a current reporting company. You can access the Company's stock quote directly from OTC Markets at www.otcmarkets.com/stock/MLCG/quote. To find out more information on the Company, visit its website at www.mlcapitalgroupinc.com.
Safe Harbor Statement:
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.